Becker's Healthcare July 3, 2024
Hospitals may see more lawsuits related to reimbursement regulations after the U.S. Supreme Court struck down the Chevron doctrine on June 28, overturning the precedent of deferring to federal agency interpretations during disputes, according to Moody’s Investor Services.
The ratings agency released a report predicting litigation would “almost certainly” increase and the heavily regulated healthcare industry would likely see litigation related to reimbursement, insurance eligibility and more. Insurers, pharmaceutical companies and patient advocacy groups could “bring lawsuits that ultimately raise costs and reduce hospital reimbursement,” according to the...
Today's Sponsors
Today's Sponsor